Perclose wins approval for closure technique:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Perclose's minimally-invasive system for the closure of arterial access sites following catheterisation procedures. The Prostar Systems were granted expedited review. Results of clinical trials submitted in support of the PMA application compared the Perclose systems, which are used in conjunction with anticoagulant and anti-platelet drug therapies, with conventional mechanical compression for site closure.